1. "Breast Medicine Service"
Formats
  1. Journal Article (2170)
  2. Meeting Abstract (1650)
  3. Review (78)
  4. Book Section (67)
  5. Editorial (42)
  6. Conference Paper (28)
  7. Guidelines (26)
  8. Correspondence (16)
  9. Miscellaneous (11)
  10. Research Letter (10)
  11. Book Whole (5)
Groups
  1. Breast Medicine Service (4103)
  2. Department of Medicine (4103)
  3. Solid Tumor Oncology Division (4103)
  4. Survivorship Research (2337)
  5. GSK Faculty (1492)
  6. Population Sciences Research Program (1339)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (758)
  3. Mark Robson (676)
  4. Neal Rosen (425)
  5. Andrew Seidman (318)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (57)
  2. 2024 (192)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (802)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (169)
  4. Annals of Oncology (158)
  5. Clinical Cancer Research (128)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (853)
  2. American Association for Cancer Research (749)
  3. Springer (329)
  4. Elsevier Inc. (322)
  5. Oxford University Press (278)
  6. Nature Publishing Group (273)

More Publishers

Results (4103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining the energetic basis for a conformational switch mediating ligand-independent activation of mutant estrogen receptors in breast cancer
    Journal Article

    Mayne, C. G.; Toy, W.; Carlson, K. E.; Bhatt, T.; Fanning, S. W.; Greene, G. L.; Katzenellenbogen, B. S.; Chandarlapaty, S.; Katzenellenbogen, J. A.; Tajkhorshid, E.
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: A simulation-based analysis
    Journal Article

    Ward, Z. J.; Atun, R.; Hricak, H.; Asante, K.; McGinty, G.; Sutton, E. J.; Norton, L.; Scott, A. M.; Shulman, L. N.
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Management of women with breast cancer and pathogenic variants in genes other than BRCA1 or BRCA2
    Review

    Robson, M.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Updated Standardized Definitions for Efficacy End Points (STEEP) in adjuvant breast cancer clinical trials: STEEP Version 2.0
    Journal Article

    Tolaney, S. M.; Garrett-Mayer, E.; White, J.; Blinder, V. S.; Foster, J. C.; Amiri-Kordestani, L.; Hwang, E. S.; Bliss, J. M.; Rakovitch, E.; Perlmutter, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Oncology patients’ perspectives on remote patient monitoring for COVID-19
    Journal Article

    Daly, B.; Lauria, T. S.; Holland, J. C.; Garcia, J.; Majeed, J.; Walters, C. B.; Zablocki, M.; Chow, K.; Strachna, O.; Giles, C. E.; more...
    JCO Oncology Practice (2021)

    Fulltext@MSK | Save
  • Trastuzumab deruxtecan in previously treated HER2-positive metastatic breast cancer: Plain language summary of the DESTINY-Breast01 study
    Editorial

    Modi, S.
    Future Oncology (2021)

    Fulltext@MSK | Save
  • RASAL2 confers collateral MEK/EGFR dependency in chemoresistant triple-negative breast cancer
    Journal Article

    Koh, S. B.; Ross, K.; Isakoff, S. J.; Melkonjan, N.; He, L.; Matissek, K. J.; Schultz, A.; Mayer, E. L.; Traina, T. A.; Carey, L. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Pooled analysis of drug-related interstitial lung disease (ILD) in 8 single-arm trastuzumab deruxtecan (T-DXd) studies
    Meeting Abstract

    Powell, C. A.; Modi, S.; Iwata, H.; Takahashi, S.; Smit, E. F.; Siena, S.; Chang, D. Y.; Fuchs, C. S.; Nie, K.; Qin, A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Multidimensional metabolomic stratification of ER+/HER2- compared to ER-/HER2- breast tumors
    Meeting Abstract

    Bussberg, V.; Tolstikov, V.; Wang, G.; Shah, P.; Searfoss, R.; Fantacone-Campbell, L.; Hooke, J. A.; Deyarmin, B.; Zingmark, R. N.; Somiari, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Monitoring circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) genomic alterations in ER positive (POS)/HER2 negative (NEG) advanced breast cancer during endocrine therapy: Correlative study of AZD9496 oral SERD phase I trial
    Meeting Abstract

    Cani, A. K.; Dolce, E. M.; Darga, E. P.; Hu, K.; Brown, M.; Liu, C. J.; Pierce, J.; Bradbury, K.; Aung, K.; Schiavon, G.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save